MGTX Live signaler | Maksimer profitt med Getagraph.com

SELG 113817 min ago

@ $6.39

Utstedt: 14 feb 2024 @ 15:30

Avkastning: -21.44%

Forrige signal: feb 13 - 15:30

Forrige signal: Kjøp

Avkastning: -2.44 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 17:27):

Stats
Dagens volum	27 767.00
Gjennomsnittsvolum	149 232
Markedsverdi	319.26M
EPS	$0 ( 2024-03-12 )
Neste inntjeningsdato	( $-0.500 ) 2024-06-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.37
ATR14	$0.0170 (0.34%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-05	Forbes Alexandria	Sell	1 000	Ordinary Shares
2024-03-12	Forbes Alexandria	Sell	2 000	Ordinary Shares
2024-02-29	Giroux Richard	Sell	13 500	Ordinary Shares
2024-01-07	Zeldin Robert K	Sell	13 773	Ordinary Shares
2024-01-14	Giroux Richard	Buy	25 000	Ordinary Shares

INSIDER POWER
-6.05
Last 100 transactions
Buy: 8 402 826 \| Sell: 8 030 781

Volum Korrelasjon

Lang: -0.03 (neutral)

Kort: -0.61 (weak negative)

Signal:(30.116) Neutral

MeiraGTx Holdings PLC Korrelasjon

10 Mest positive korrelasjoner
ZG	0.844
FCAL	0.831
Z	0.824
HYLS	0.82
OPBK	0.817
VCIT	0.805
FMB	0.803

10 Mest negative korrelasjoner
SOVO	-0.843

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

MeiraGTx Holdings PLC Korrelasjon - Valuta/Råvare

0.15
( neutral )

-0.07
( neutral )

0.00
( neutral )

0.21
( neutral )

0.33
( neutral )

-0.34
( neutral )

MeiraGTx Holdings PLC Økonomi

Annual	2023
Omsetning:	$14.02M
Bruttogevinst:	$287 000 (2.05 %)
EPS:	$-1.490

FY	2023
Omsetning:	$14.02M
Bruttogevinst:	$287 000 (2.05 %)
EPS:	$-1.490

FY	2022
Omsetning:	$15.92M
Bruttogevinst:	$7.20M (45.21 %)
EPS:	$-3.16

FY	2021
Omsetning:	$37.70M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.800

Financial Reports:

No articles found.

MeiraGTx Holdings PLC

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.